The Diagnostic Power of the Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Biochemical Recurrence After Primary Curative Treatment in Patients with Prostate Cancer: A Single-center Experience

Journal Title: European Archives of Medical Research - Year 2019, Vol 35, Issue 4

Abstract

Objective: Our study aimed to investigate the efficacy of Gallium-68 (68Ga) prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) in terms of focus detection in the presence of biochemical recurrence (BCR) after primary curative treatment in patients with prostate cancer (PCa). Methods: This study included 34 PCa patients who underwent 68Ga-PSMA PET-CT for BCR following radical prostatectomy (RP) or primary curative radiotherapy (RT), between August 2017-December 2018 at Okmeydanı Training and Research Hospital, Clinic of Nuclear Medicine. Results: Thirteen patients (38.2%) had RP and 21 (61.8%) had RT. PSMA-positive lesion was detected in 21 (61.7%) of 34 patients. PSMA positive lesion was present in six of 13 patients (46.1%) in the RP group and 15 of the 21 patients (71.4%) in the RT group. There was a PSMA-positive lesion in five out of 13 patients with serum prostate-specific antigen (PSA) values of 0.01-1 ng/mL, in five of eight patients with serum PSA values of 1-2 ng/mL, in four of five patients with serum PSA values of 2-5 ng/mL, and in seven of eight patients with serum PSA values of >5 ng/mL. PSA levels of PSMA-positive patients were found to be significantly higher than those of PSMA-negative, whereas PSA-positive and negative patients did not differ significantly in terms of PSA doubling time, time to BCR, and Gleason score. Conclusion: 68Ga-PSMA PET-CT is an effective method in the diagnosis of BCR after primary curative treatment in PCa patients.

Authors and Affiliations

Sevda Sağlampınar Karyağar, Selvi Tabak Dinçer

Keywords

Related Articles

Comparison of the Effects of Smoking and Smokeless Tobacco “Maras Powder” Use on Pulmonary Function, Electrocardiogram and Other Parameters

Objective: Through the years, tobacco has been used in many ways. While the most common way of consumption is through smoking cigarettes, smokeless use by chewing or nasal snuffing are also quite common. Smokeless tobacc...

Inflammatory Markers in Hyperemesis Gravidarum

Objective: This study aims to investigate the role of inflammation in the pathophysiology of hyperemesis gravidarum (HEG). Methods: This prospective study was conducted in the Department of Obstetrics and Gynecology at...

The Diagnostic Power of the Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Biochemical Recurrence After Primary Curative Treatment in Patients with Prostate Cancer: A Single-center Experience

Objective: Our study aimed to investigate the efficacy of Gallium-68 (68Ga) prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) in terms of focus detection in the presence...

Measles-Mumps-Rubella Vaccination of Patients with Egg Allergy: One Center Experience

Objective: Measles-Mumps-Rubella (MMR) vaccine is a live vaccine. Measles and mumps are cultured in chick embryo fibroblasts, and rubella is cultured in human diploid cell culture. MMR vaccine contains egg protein and th...

Evaluation of the Effects of COVID-19 Pandemic Among Patients with Inflammatory Bowel Diseases

Objective: The Coronavirus Disease-2019 (COVID-19) pandemic continues to be a concern, especially to people with chronic diseases across the entire world. During this pandemic, we undertook an investigation to assess how...

Download PDF file
  • EP ID EP675914
  • DOI 10.4274/eamr.galenos.2019.02418
  • Views 109
  • Downloads 0

How To Cite

Sevda Sağlampınar Karyağar, Selvi Tabak Dinçer (2019). The Diagnostic Power of the Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Biochemical Recurrence After Primary Curative Treatment in Patients with Prostate Cancer: A Single-center Experience. European Archives of Medical Research, 35(4), -. https://europub.co.uk/articles/-A-675914